Page 136 - Biomarkers for risk stratification and guidance in heart failure
P. 136
A
B
Prognostic impact of change in NT-proBNP versus change in eGFR.
Figure 1. Kaplan-Meier curve for the combined endpoint HF readmission or mortality (a) and mortality (b) by change in eGFR and NT-proBNP.
Univariate predictors of outcome.
Also in univariate analysis, decrease versus increase in eGFR was no risk factor (HR for for the combined endpoint of HF readmission or mortality eGFR 1.19, 95% CI 0.79-1.78, P=0.410, see table 3.).
135
6
